Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, Sichuan, China.
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, OX3 9DU, UK.
BMC Med Res Methodol. 2020 Oct 19;20(1):260. doi: 10.1186/s12874-020-01144-2.
A competing interest is an important source of bias in research and disclosure is frequently employed as a strategy to manage it. Considering the importance of systematic reviews (SRs) and the varying prevalence of competing interests in different research fields, we conducted a survey to identify the range of competing interests in SRs assessing surgical interventions or devices and explored the association between the competing interest disclosures and authors' conclusions.
We retrieved SRs of surgical interventions and devices published in 2017 via PubMed. Information regarding general characteristics, funding sources, and competing interest disclosures were extracted. We conducted a descriptive analysis of the studies' characteristics and compared them between Cochrane SRs (CSRs) and non-Cochrane SRs using the Chi-square test. Results were expressed as odds ratio and their 95% confidence interval.
One hundred fifty-five SRs published in 2017 were included in the study. More than half of the SRs (58.7%) reported their funding sources and 94.2% reported authors' competing interest disclosures. Among 146 SRs that stated competing interest disclosures, only 35 (22.6%) SRs declared at least one author had a competing interest. More than 40 terms were used to describe competing interests. Cochrane SRs (CSRs) were more likely to provide a detailed description of competing interests compared to those in non-CSRs (48.0% versus 25.4%, P = 0.023). No association between positive conclusions and competing interest disclosures was found (P = 0.484, OR = 0.43, 95%CI: 0.08, 2.16). In the subgroup analyses, SRs stating no competing interest disclosure were more likely to report positive conclusions than those stating at least one type of competing interest, but the difference is not significantly different (P = 0.406, OR = 1.38, 95%CI: 0.64, 2.98).
In surgical SRs, there is a high percentage of competing interest disclosures but without detailed information. The identification and statement of competing interests with a detailed description, particularly the non-financial ones, needs improvement. Some efficient and effective methods/tools for identifying, quantifying, and minimizing potential competing interests in systematic reviews remains valuable.
利益冲突是研究中一个重要的偏倚来源,披露利益冲突通常被用作管理偏倚的策略。鉴于系统评价(SRs)的重要性以及不同研究领域中利益冲突的不同发生率,我们进行了一项调查,以确定评估手术干预或器械的 SR 中利益冲突的范围,并探讨利益冲突披露与作者结论之间的关联。
我们通过 PubMed 检索了 2017 年发表的手术干预和器械的 SR。提取了研究的一般特征、资金来源和利益冲突披露信息。我们对研究的特征进行了描述性分析,并使用卡方检验比较了 Cochrane SR(CSRs)和非 Cochrane SR 之间的差异。结果表示为比值比及其 95%置信区间。
共纳入了 2017 年发表的 155 篇 SR。超过一半的 SR(58.7%)报告了资金来源,94.2%报告了作者的利益冲突披露情况。在 146 篇声明利益冲突披露的 SR 中,只有 35 篇(22.6%)SR 声明至少有一位作者存在利益冲突。有 40 多个术语用于描述利益冲突。与非 CSR 相比,CSRs 更有可能提供详细的利益冲突描述(48.0%比 25.4%,P=0.023)。未发现阳性结论与利益冲突披露之间存在关联(P=0.484,OR=0.43,95%CI:0.08,2.16)。在亚组分析中,声明没有利益冲突披露的 SR 更有可能报告阳性结论,而声明至少有一种类型的利益冲突的 SR 则不然,但差异无统计学意义(P=0.406,OR=1.38,95%CI:0.64,2.98)。
在外科 SR 中,利益冲突披露的比例较高,但信息不详细。需要改进识别和详细描述利益冲突的方法,特别是非财务利益冲突的描述。一些用于识别、量化和最小化系统评价中潜在利益冲突的有效方法/工具仍然很有价值。